Health
Identifying Platinum Chemotherapy Resistance in Patients With Ovarian Cancer – Technology Networks
Researchers have discovered a way to predict which patients with ovarian cancer are resistant to platinum chemotherapy.
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.
Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
-
Noosa News22 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
Noosa News17 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News5 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News18 hours agoFarmgate Backpackers leads with integrity amid industry challenges